January 27 2017. On January 25, 2017, The Laryngoscopereported the discovery of researchers at Thomas Jefferson University of mechanisms associated with the drug metformin against cancer of the head and neck. "This study is the first step in showing how metformin acts on head and neck tumors, and we are excited that it could eventually offer patients a method of improving their outcomes with few side effects," announced senior author Ubaldo Martinez-Outschoorn.
A promising new immunotherapy drug as gained expanded approval from federal regulators for patients whose cancers have a specific genetic signature — the first time a drug has been cleared for use not tied to the site of a tumor.
The U.S. Food and Drug Administration ruling opens the door to redefining cancer, and treatment, not by site — like breast, prostate, or lung cancer — but by the genetic blueprint of the tumor, regardless of where it appears in the body.
Major news on the glyphosate front: the first ever independent analysis of the complete confidential data set sent by industry to the EU for the re-licensing of glyphosate shows EFSA and ECHA’s safety assessment would have failed to identify several cases of tumors and cancer following an exposure to the substance. It is high time the complete data set is published in full to enable scrutiny by the scientific community.
Ty Bollinger, April 2016
Breast cancer awareness month has just gotten underway, which means the Great Pink Push is being unleashed.
Dena Schmidt, April 10, 2016
The health and cancer-fighting benefits of broccoli have been known for some time.
health freedom alliance, 9 February 2016
A new study links organophosphate pesticides with vastly decreased lung function.